Literature DB >> 18445612

Gender differences in colorectal cancer incidence, mortality, hospitalizations and surgical procedures in Canada.

Ru-Nie Gao1, C Ineke Neutel, Elaine Wai.   

Abstract

BACKGROUND: Over the past few decades there have been changes in incidence and mortality of colorectal cancer.
OBJECTIVE: To examine gender differences in incidence, hospitalization, hospital-based procedures and mortality for colorectal cancer.
METHODS: Data were derived from the Hospital Morbidity Database, Canadian Cancer Registry and the Canadian Mortality Database.
RESULTS: Overall incidence and mortality rates for colorectal cancer are decreasing, but remain substantially higher for males. Absolute numbers of cases are similar for men and women. The top subsite for men was rectal cancer, which was third highest for women, whereas right colon cancer was highest for women. Male/female ratios for incidence and surgeries were highest for distal cancer and are increasing with time.
CONCLUSIONS: Although overall incidence rates have shown a decline, absolute numbers of new colorectal cancer cases have increased. While men have higher colorectal cancer rates, women have similar numbers and screening should target both equally. Over the years, colorectal cancer subsites are showing a rightward shift, i.e. an increase in proximal subsites, but a leftward shift in male/female ratios, i.e. a greater decrease for the more distal subsites in females. The lower rates for women for distal cancer are compatible with a degree of hormonal protection based on oral contraceptive and hormone replacement therapy. Colorectal cancer will continue to be a considerable public health problem in the foreseeable future.

Entities:  

Mesh:

Year:  2008        PMID: 18445612     DOI: 10.1093/pubmed/fdn019

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


  25 in total

1.  Gender differences in colorectal cancer incidence in the United States, 1975-2006.

Authors:  Peter N Abotchie; Sally W Vernon; Xianglin L Du
Journal:  J Womens Health (Larchmt)       Date:  2011-12-13       Impact factor: 2.681

2.  Gender differences in colorectal cancer survival in Japan.

Authors:  Kenjiro Kotake; Michio Asano; Heita Ozawa; Hirotoshi Kobayashi; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2015-07-07       Impact factor: 3.402

3.  A retrospective analysis of 2000 cases with colorectal carcinoma.

Authors:  G Basdanis; A Mekras; V N Papadopoulos; E Karamanlis; D Paramythiotis; D Mekras; D Panagiotou; S Panidis; A Michalopoulos
Journal:  Tech Coloproctol       Date:  2011-10       Impact factor: 3.781

4.  Polymorphisms in the DUSP10 gene are associated with sex-specific colorectal cancer risk in a Han population.

Authors:  Xianglong Duan; Ya Gao; Hua Yang; Tian Feng; Tianbo Jin; Yanbin Long; Chao Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

5.  Is there a sex effect in colon cancer? Disease characteristics, management, and outcomes in routine clinical practice.

Authors:  J S Quirt; S Nanji; X Wei; J A Flemming; C M Booth
Journal:  Curr Oncol       Date:  2017-02-27       Impact factor: 3.677

6.  Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin.

Authors:  Michael A Gordon; Wu Zhang; Dongyun Yang; Syma Iqbal; Anthony El-Khouiery; Fumio Nagashima; Georg Lurje; Melissa Labonte; Peter Wilson; Andy Sherrod; Robert D Ladner; Heinz-Josef Lenz
Journal:  Pharmacogenomics       Date:  2011-01       Impact factor: 2.533

7.  Clinical Evaluation of IntelliPlex™ KRAS G12/13 Mutation Kit for Detection of KRAS Mutations in Codon 12 and 13: A Novel Multiplex Approach.

Authors:  Chi-Long Chen; Chi-Kuan Chen; Chung-Liang Ho; Wei-Ming Chi; Chien-Hsuan Yeh; Shian-Pin Hu; Peter Friebe; Stuart Palmer; Chin-Shiou Huang
Journal:  Mol Diagn Ther       Date:  2019-10       Impact factor: 4.074

8.  Sex-biased differences in the correlation between epithelial-to-mesenchymal transition-associated genes in cancer cell lines.

Authors:  Sun Young Kim; Seungeun Lee; Eunhye Lee; Hyesol Lim; Ji Yoon Shin; Joohee Jung; Sang Geon Kim; Aree Moon
Journal:  Oncol Lett       Date:  2019-10-29       Impact factor: 2.967

9.  Cost-effectiveness of oxaliplatin in the adjuvant treatment of colon cancer in Canada.

Authors:  C L Attard; J A Maroun; K Alloul; D T Grima; L M Bernard
Journal:  Curr Oncol       Date:  2010-02       Impact factor: 3.677

10.  A novel nomogram with preferable capability in predicting the overall survival of patients after radical esophageal cancer resection based on accessible clinical indicators: A comparison with AJCC staging.

Authors:  Xinye Li; Jinming Xu; Linhai Zhu; Sijia Yang; Li Yu; Wang Lv; Jian Hu
Journal:  Cancer Med       Date:  2021-06-15       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.